A radioimmunoassay for cxl-fetoprotein in human maternal serum at 15-20 weeks' gestation using polyethylene glycol to separate bound and free antigen is described. A number of variables has been investigated to define optimal conditions for use at this gestation. The method gives results which agree with those from a double-antibody technique. It has good precision in the critical concentration range, and recoveries are satisfactory. The importance of including sufficient serum protein in the analytical system is stressed.
Recent reports emphasise the value of maternal serum oo-fetoprotein (cxIF) measurements in the prenatal diagnosis of fetal neural tube defects (Leighton et al., 1975; Vince et al., 1975; UK Collaborative Study, 1977) . Our own experience indicates the need for a simple, inexpensive, and properly characterised method to detect increases at 15 to 20 weeks' gestation. Good precision is required in the range 50-250 j-Lg/I, and the assay should be capable of handling a large throughput of samples.
Several groups have used a double antibody radioimmunoassay (Ruoslahti and Seppala, 1971; Purves and Purves, 1972; Nishi and Hirai, 1973; Leek and Chard, 1974; Masseyef et al., 1974; Vince et al., 1975) . The use of polyethylene glycol (PEG) to precipitateantibody-bound antigen in radioimmunoassays (Desbuquois and Aurbach, 1971 ) has been used for cxIF by Leek and Chard (1974) and Vince et al. (1975) to give quicker and cheaper separations.
We describe here a fuller investigation of a radioimmunoassay method for maternal serum cxIF using PEG based on that of Leek and Chard (1974) . Three cxIF standard preparations and four antisera have been evaluated. STANDARDS (a) Highly purified cxIF was provided by Dr Nishi (Japan) as a desiccated powder. It was dissolved in phosphate buffer at a concentration of 1 gil and stored in 1O-j-L1 aliquots at -20°C. These were used for iodination and for preparing stock standards by dissolving several aliquots in cxIF-free serum to give a concentration of 500 to 1000 j-Lg/l; this preparation was designated NIS. Working standards covering the range 8-500 j-Lg/l were prepared by further dilution with cxIF-free serum.
(b) One ampoule of pooled cord serum (code 72/227) from the National Institute of Biological Standards and Control (Holly Hill, Hampstead, London) was dissolved in 200 rnI phosphate buffer containing 2 g bovine serum albumin (BSA) and stored deep frozen in 1-ml lots. The ampoule was stated to contain 96500 units of cxIF (one unit is approx 1 ng). This diluted serum was designated MRC.
(c) Purified cxIF, prepared by Ruoslahti and Seppala, was donated via Dr P. C. Ganguli, Manchester Royal Infirmary, as a 200 mg/I solution in 50 mmol/l phosphate buffer, pH 7·0. It was added to cxIF-free serum and stored at a concentration of 1 mg/l in deep frozen lots coded RUO.
PATIENTS' SERA
All sera were obtained from pregnant women of between 15 and 20 weeks' gestation. Phosphate buffer 50 mmolll, pH 7·4 Make 15'4 g Na2HP04, 2H20, and 1'092 g of NaH2P04, 2H20 to one litre with water. The pH should be 7'3-7'5.
Diluent This is a 2 gil solution of BSA in the phosphate buffer.
Q(lF-free sera Five pools were prepared as follows: 600 ml from three male blood donors; 200 ml from one male blood donor; 10 ml from a normal male; 100 ml from 20 and 200 ml from 50 non-pregnant women without liver disease. Greenwood et al. (1963) was used to radioiodinate Q(lF supplied by Nishi. The reagents were added to a small polystyrene test tube in the following order and mixed by a small steel magnetic stirrer: 20 fJ-I phosphate buffer, 10 fJ-I cx1F solution, 10 fJ-I Na 125 1, 10 fJ-I chloramine-T (25 rng per 10 rnl phosphate buffer). The reaction was stopped after 20 s by the addition of 150 fJ-g sodium metabisulphite in 500 fJ-I phosphate buffer.
The reaction products were transferred to a 200 x 12 em column of Sephadex G-50 previously treated with 1 rnl 10% BSA solution. The column was eluted with 30 ml phosphate buffer. Fifteen l-ml fractions were collected in 0'1 ml 10% BSA and counted. The peak labelled protein fractions were used in the assay. The incorporation of radioactivity ranged between 20 and 50 %, and the specific activity of the product varied from 20 to 50 fJ-Ci/fJ-g.
GENERAL RADIOIMMUNOASSAY PROCEDURE Serum specimens or standards (50 fJ-1) were mixed with diluent (350 fJ-I) in LPa tubes. Additions (50 fJ-I) of antiserum and labelled cxlF were made with Repettes. Unless mentioned otherwise, the dilution of antiserum used was 1 :550 (51), 1:2700 (52), 1 :1750 (53), and 1:1000 (54); the amount of labelled alF was 125 pg. Incubation was carried out overnight at room temperature in this final volume of 500 fJ-I except where stated otherwise. Additions of further reagents were then made with automatic dispenser pipettes.
In the case of PEG precipitation, 1 rnl of 180 g/I PEG was added followed by mixing and centrifugation at 5-1O°C. Second antibody precipitation was achieved by adding 50 fJ-I of diluted second antibody and 50 fJ-I of sheep serum, diluted 1:400. The reaction was allowed to proceed for 18-24 h at 4°C before centrifugation at 4°C. In each case, after centrifugation for 20 min at 2200 rpm, the clear supernatant was removed by aspiration before the precipitate was counted until at least 5000 counts had been registered.
OPTIMISATION OF FACTORS AFFECTING THE RADIOIMMUNOASSAY USING PEG

Titration ofantisera
The dilution of the four antisera as added to the assay tube was varied from 1:500 to 1:128 000. Incubation was with labelled cxlF (125 pg in 50 p.1) only, at 4°C for 72 h, after which cxlF-free serum (50 p.1) was added to facilitate precipitation of the bound radioactivity with PEG.
Potential sensitivity of the antisera Similar dilution curves were set up, adding to each tube 50 p.1 of serum containing 0, 5, or 100 p.gjl of cxlF. On the basis of the results a second set of curves was prepared using the optimal antiserum dilution (see above) and covering a range of cxlF concentration of 7'8-500 p.g/J. Incubation was for 18 h at 17°C.
Time ofincubation
The efficiency of binding of labelled cxlF to antibody was studied using incubation times of 3, 6, 12, 18, and 24 h at room temperature for the usual dilution of each antiserum, adding 50 p.I of cxlF-free serum, of which several different preparations were studied.
PEG concentration
The effect on the precipitation procedure was investigated after altering the concentration of the PEG solution up to 300 gjl.
Effect of serum volume
Using antiserum 52, the effect on protein precipitation by PEG of varying the volume of cxlF-free serum was assessed over the ranges 0-21 and 10-150 p.1. Using antisera 52 and 54, standard curves were set up using cxlF dissolved in either cxlF-free serum or the buffer diluent; 50 p.1 were added to each tube. Precipitation of bound radioactivity was achieved when the buffer diluent was used by adding cxlF-free serum at the end of the incubation period.
Effect ofproteolytic enzyme inhibitors
Using antiserum 54, the possible contribution of proteolytic enzymes in cxlF-free serum was studied by preparing pairs of standard curves with and without added cxlF-free serum as before. In one pair, trasylol (50 p.1) was added to each tube, and in another pair benzamidine hydrochloride (50 p.1) was used. The remaining pair had no inhibitor added. The volume of diluent was adjusted so that the final assay volume was always 500 p.1.
Effect of BSA on precipitation of bound radioactivity
This was investigated with antiserum 52 by altering the concentration of BSA in the diluent from 2 to 20 gjl.
PERFORMANCE OF FINAL PROCEDURE
Non-specific binding of serum
The effect was measured in 30 sera by excluding the antiserum from the reaction mixture.
Response parameters of three standards and four antisera Standard curves were investigated using the three standard preparations, NIS, RUO, MRC, and the four antisera under the optimal conditions determined earlier. Comparisons were made following logit transformation-and covered a concentration range of 30-500 p.gjI.
Serum dilution curves
Six cord sera diluted 1:333 with cxlF-freeserum and 10 samples of maternal sera were further diluted 1:2, 1 :3, 1 :4, 1:6, and 1:8 with cxlF-free serum before assay.
Precision studies
The within-assay precision was calculated from the duplicate estimates for 148 sera covering several assays. Between-assay precision was assessed by analysing three pooled sera in each of 21 batches.
Recovery experiments
Assays were done on 31 maternal sera with cxlF content of up to 74 p.gjl, before and after the addition of sufficient cxlF in 50 p.1 of cxlF-free serum to increase the concentration by 86'7 p.gjI. The NIS preparation was used with antiserum 54.
Comparison with double antibody method
In one batch 39 different sera with cxlFcontent in the range 10-250 p.gjl were assayed with antiserum 54 using the above PEG method and the double antibody method outlined under 'general radioimmunoassay procedure'.
Comparison offour antisera
The results of assaying 41 sera for cxlF using each antiserum at its usual dilution were compared over the range 15-230 p.g/l.
Results
OPTIMISATION OF FACTORS
Each antiserum is potentially useful (Fig. 1 50% maximal binding occurs at dilutions of 1:14 000 (51), 1:90 000 (52), 1:22 000 (53), and 1 :18000 (54). All show similar binding when in excess. All are satisfactory for Cl:IF assay at a concentration of 100 fJ-g/I but only antiserum 51 is potentially suitable for 5 fJ-g/l (Fig. 2) . For the higher level, dilutions of 1:550 (51), 1 :2700 (52), 1 :1750 (53), and 1:1000 (54) seem appropriate. Under such conditions all antisera gave satisfactory standard curves (Fig. 3) , and these dilutions were used thereafter. There was no significant difference at each of the incubation times for the different antisera and Cl:IF-free serum preparations ( Fig. 4) . Equilibrium occurs at 18 to 24 h but binding is less with shorter times. Accordingly, overnight incubation (18 h) was selected. With each antiserum, maximal precipitation occurs at a PEG concentration of 180-220 gil (Fig. 5) , and there is little precipitation of Cl:IF in the absence of antiserum The effect of varying the carrier serum volume was surprising. A marked increase in the percentage of radioactivity precipitated, without change in nonspecific binding, occurred up to 21 iLl of added cxIF-free serum (Fig. 6) but there was no further change up to 150 iLl. Some serum must therefore be present in the system, and this was standardised at 50 iLl, at which amount the bound fraction of the radioisotope increased at all concentrations of cxIF (Fig. 7 ). Although this could be explained by more efficient precipitation by PEG when an adequate amount of protein is present, it could also be a consequence of partial destruction of cxIF by proteolytic enzymes in the cxIF-free serum or diluent. In the investigation with proteolytic enzyme inhibitors (Fig. 8 ), although the inhibitors themselves affect the shape of the curve in the absence of cxIF-free serum, the increased binding that follows its addition is not diminished by either inhibitor. The concentration of B8A in the diluent was without effect on the precipitation of radioactive protein over the range 2-20 g/I, and 2 g/I was therefore used finally.
PERFORMANCE OF OPTIMISED PROCEDURE
The mean percentage of bound counts in the serum blank was 5'22 ± 0'10 (8E) and in the reagent blank 3'39 ± 0·09 (8E), giving an acceptably small but significant percentage non-specific binding of serum of 1'83 ± 0'14 (8£).
The slopes of the lines relating the logit transformation (vs) on the ordinate to the logarithm of M. H. Khadempour, 1. Laing, and A. H. Gowenlock the cxIF concentration on the abscissa for the different standard preparations were parallel for each of the antisera. In order to make comparisons between the three standard preparations the concentration in RUO and MRC which gives the same binding as 100 iLg/1 of NI8 was recorded for each antiserum (Table 1 ). The validity of preliminary dilution of sera containing high levels of cxIF was suggested by the fact that similar log-legit plots of diluted sera were parallel to those of diluted standards. The results derived from diluted sera are less satisfactory at the higher dilutions, as indicated in Table 2 . The within-assay precision results derived from duplicates were divided into groups. The coefficient of variation (CY %) and concentration range (iLg/l) given in parentheses were: 16·4 (1Q-20) for 26 samples, 9·4 (20-40) for 32 samples, 3·8 (40-150) for 71 samples, and 3'6 (150-260) for 19 samples, giving an overall figure of 5·1 % based on 148 samples covering the whole range. The betweenassay CY over 21 batches for three pooled sera was: 7·9 (44'9), 6·7 (73'9), and 5'4 (209), the figure in parentheses being the mean concentration (iLg/l) for each pool. The within-assay CYs of the optimised PEG and the double antibody method applied to the same 39 sera were not significantly different, being 5'6 and 5'3 % respectively, nor was there any difference at different concentration ranges in this group.
Recovery studies gave satisfactory results. The mean increase in cxIFcontent (iLg/l)was 86'86 ± 1'45 (8E), and the mean content of the cxIF preparation added was 86'67 ± 0'88 (8E), giving a percentage recovery of 100·2 ± 1·7 (8£). An indication of ·For each serum, its apparent concentration was calculated from the result for the diluted material and expressed as a percentage of the known concentration of the undiluted serum. For each dilution the mean and SE refer to the number of different sera indicated. was y = 0·977 x + 1·64. The 95 % confidence limits on the slope were 0'94 to 1'01, indicating no systematic difference between the two methods.
The results from the four antisera (Table 3) show little difference between 52, 53, and 54. Comparison was made by arbitrary selection of antiserum 54 as a reference serum plotted on the abscissa, calculating separately the regression line for each of the other antisera on the ordinate. All three correlation coefficients are highly significant (p < 0'001). The slopes of the lines and the intercepts were not significantly different from 1 and 0, respectively, for antisera 52 and 53, but for antiserum 51 the slope was significantly greater than 1.
Discussion
The selection of the optimal conditions for the different variables in this assay has given results similar to those used by Leek and Chard (1974) but have been extended to other aspects not discussed by them. The method of Vince et al. (1975) differs significantly by using a different diluent, pH, and buffer, and a different carrier protein in bovine gamma-globulin. A lower concentration of PEG is used and the reagent is added before the incubation step. In assessing the performance of our optimised method the opportunity was taken to study different standard preparations and antisera.
The conditions for satisfactory precipitation of bound antigen by PEG are fairly critical and depend on the presence of a minimal amount of serum protein. If a serum sample has to be diluted before addition to the assay system, this should be done with cxIF-free serum. The change in the shape of the standard curve, which occurs in the presence of serum proteins, is most likely attributable to its effects on the precipitation step and not to proteolytic destruction of Or:lF. Chayvialle and Ganguli (1973) found no interaction of human albumin, HCG, IgG, C-reactive protein, or transferrin with Or:lF in the usual concentrations present.
The performance of the method compares well with other published techniques. Thus the range of percentage recovery found (87-114) is very similar to 95-114 and 92-113 quoted by Chayvialle and Ganguli (1973) and Vince et al. (1975) , respectively. The accuracy and precision are no different from those of the double antibody technique with which it was compared directly. Our mean within-assay precision of 5'1 % is similar to the figures of 5 % and 7·5 % reported by Leek and Chard (1974) and Chayvialle and Ganguli (1973) , respectively. Simil-arly, our between-assay precision of 5'4% to 7'9% compares favourably with the figures of 10% and 12'5 % found by the last two pairs of authors. The PEG method has the advantage of speed over the double antibody method, and the precipitate is mechanically more stable during aspiration of supernatant fluid. The lower limit of usefulness of our method is 10 p.gjl (Fig. 3) when the conditions are adjusted for use of the assay with maternal sera. Similar sensitivity was found by Leighton et al. (1975) and Vince et al. (1975) . More sensitive techniques with lower limits of detection of 0'1 to 1'5 p.gjl are more appropriate for normal human sera from the non-pregnant patient and have been described by Chayvialle and Ganguli (1973) , Masseyeff et al. (1974) , Ruoslahti et al. (1974) , and Waldman et al. (1973) .
Of the standard preparations studied, NIS and RUO are highly purified whereas MRC is a pooled cord serum. All three gave qualitatively similar dose response curves. The quantitative difference noted between the purified preparations might indicate contamination with different proteins or other material or arise from different degrees of denaturation during purification.
The four antisera were raised to different preparations of human Or:lF, three in the rabbit and one in the goat. When using the NIS standard, three of these, including the one raised against NIS, gave very similar results but the Organon rabbit antiserum gave consistently higher figures. Even when using one of the three similar antisera it would be undesirable to change antisera once the normal ranges at different stages of pregnancy had been determined without very careful consideration of the likely effect it would have on the level of Or:lF considered to require further clinical action. The same considerations apply to a change in standard material.
